LLY logo

Eli Lilly And Company (LLY) Free Cash Flow

Annual FCF

-$3.15 B
-$7.75 B-168.52%

31 December 2023

LLY Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

-$458.90 M
-$522.30 M-823.82%

30 September 2024

LLY Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

-$2.28 B
+$1.35 B+37.29%

30 September 2024

LLY TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LLY Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-168.5%+74.7%-1279.8%
3 y3 years-170.5%-139.0%-149.2%
5 y5 years-225.8%-139.3%-185.2%

LLY Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-158.5%at low-126.0%+76.6%-139.1%+41.6%
5 y5 years-158.5%at low-123.3%+76.6%-139.1%+41.6%
alltimeall time-150.6%at low-121.8%+76.6%-136.5%+41.6%

Eli Lilly And Company Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
-$458.90 M(-823.8%)
-$2.28 B(-37.3%)
June 2024
-
$63.40 M(-23.8%)
-$3.63 B(-6.9%)
Mar 2024
-
$83.20 M(-104.2%)
-$3.90 B(+23.6%)
Dec 2023
-$3.15 B(-168.5%)
-$1.96 B(+8.4%)
-$3.15 B(+1811.5%)
Sept 2023
-
-$1.81 B(+786.4%)
-$164.90 M(-105.1%)
June 2023
-
-$204.40 M(-124.7%)
$3.21 B(-15.2%)
Mar 2023
-
$827.10 M(-19.2%)
$3.79 B(-17.7%)
Dec 2022
$4.60 B(-14.6%)
$1.02 B(-34.5%)
$4.60 B(-13.8%)
Sept 2022
-
$1.56 B(+323.2%)
$5.34 B(+7.9%)
June 2022
-
$369.70 M(-77.5%)
$4.95 B(-15.0%)
Mar 2022
-
$1.64 B(-6.8%)
$5.82 B(+8.1%)
Dec 2021
$5.39 B(+20.5%)
$1.76 B(+49.9%)
$5.39 B(+16.6%)
Sept 2021
-
$1.18 B(-5.5%)
$4.62 B(-4.5%)
June 2021
-
$1.24 B(+3.2%)
$4.84 B(-13.1%)
Mar 2021
-
$1.21 B(+21.1%)
$5.56 B(+24.5%)
Dec 2020
$4.47 B(+28.3%)
$995.70 M(-28.4%)
$4.47 B(-12.5%)
Sept 2020
-
$1.39 B(-29.4%)
$5.11 B(+4.6%)
June 2020
-
$1.97 B(+1675.2%)
$4.89 B(+32.7%)
Mar 2020
-
$111.10 M(-93.2%)
$3.68 B(+5.8%)
Dec 2019
$3.48 B(+39.0%)
$1.64 B(+40.1%)
$3.48 B(+30.4%)
Sept 2019
-
$1.17 B(+52.6%)
$2.67 B(-19.6%)
June 2019
-
$766.20 M(-958.0%)
$3.32 B(+49.9%)
Mar 2019
-
-$89.30 M(-110.8%)
$2.22 B(-11.5%)
Dec 2018
$2.51 B(-27.4%)
$825.00 M(-54.7%)
$2.51 B(-14.5%)
Sept 2018
-
$1.82 B(-634.8%)
$2.93 B(+15.3%)
June 2018
-
-$340.70 M(-270.4%)
$2.54 B(-41.0%)
Mar 2018
-
$200.00 M(-84.0%)
$4.31 B(+24.9%)
Dec 2017
$3.45 B(-8.2%)
$1.25 B(-12.8%)
$3.45 B(-7.8%)
Sept 2017
-
$1.43 B(+0.3%)
$3.74 B(-0.0%)
June 2017
-
$1.43 B(-316.3%)
$3.74 B(+7.9%)
Mar 2017
-
-$660.90 M(-142.9%)
$3.47 B(-7.6%)
Dec 2016
$3.76 B(+180.9%)
$1.54 B(+7.5%)
$3.76 B(+41.4%)
Sept 2016
-
$1.43 B(+24.0%)
$2.66 B(+32.5%)
June 2016
-
$1.16 B(-409.7%)
$2.01 B(+39.5%)
Mar 2016
-
-$373.40 M(-184.5%)
$1.44 B(+7.5%)
Dec 2015
$1.34 B(-53.7%)
$441.90 M(-43.4%)
$1.34 B(-14.8%)
Sept 2015
-
$781.20 M(+32.7%)
$1.57 B(-26.6%)
June 2015
-
$588.70 M(-224.4%)
$2.14 B(-9.0%)
Mar 2015
-
-$473.40 M(-170.3%)
$2.35 B(-18.8%)
Dec 2014
$2.89 B(-37.7%)
$673.80 M(-50.1%)
$2.89 B(-14.9%)
Sept 2014
-
$1.35 B(+68.9%)
$3.40 B(-10.3%)
June 2014
-
$799.00 M(+1036.6%)
$3.79 B(-15.6%)
Mar 2014
-
$70.30 M(-94.1%)
$4.49 B(-3.3%)
Dec 2013
$4.64 B(+8.9%)
$1.18 B(-32.0%)
$4.64 B(+0.6%)
Sept 2013
-
$1.74 B(+15.8%)
$4.61 B(+9.7%)
June 2013
-
$1.50 B(+577.6%)
$4.20 B(+10.8%)
Mar 2013
-
$221.50 M(-80.8%)
$3.79 B(-11.0%)
Dec 2012
$4.26 B(-23.1%)
$1.15 B(-13.3%)
$4.26 B(-10.7%)
Sept 2012
-
$1.33 B(+21.6%)
$4.77 B(-7.7%)
June 2012
-
$1.09 B(+58.7%)
$5.17 B(-7.3%)
Mar 2012
-
$688.20 M(-58.6%)
$5.57 B(+0.6%)
Dec 2011
$5.54 B(-2.3%)
$1.66 B(-3.7%)
$5.54 B(-5.0%)
Sept 2011
-
$1.72 B(+15.1%)
$5.83 B(+2.6%)
June 2011
-
$1.50 B(+128.0%)
$5.68 B(+2.5%)
Mar 2011
-
$657.10 M(-66.4%)
$5.54 B(-2.2%)
Dec 2010
$5.67 B(+62.9%)
$1.95 B(+24.0%)
$5.67 B(+5.2%)
Sept 2010
-
$1.58 B(+16.1%)
$5.39 B(+9.0%)
June 2010
-
$1.36 B(+73.4%)
$4.94 B(+14.1%)
Mar 2010
-
$782.90 M(-53.2%)
$4.33 B(+24.5%)
Dec 2009
$3.48 B(-44.1%)
$1.67 B(+47.8%)
$3.48 B(-11.1%)
Sept 2009
-
$1.13 B(+51.6%)
$3.91 B(-16.6%)
June 2009
-
$746.40 M(-1180.2%)
$4.69 B(-0.7%)
Mar 2009
-
-$69.10 M(-103.3%)
$4.73 B(-24.1%)
Dec 2008
$6.23 B(+52.9%)
$2.10 B(+10.2%)
$6.23 B(+4.0%)
Sept 2008
-
$1.91 B(+145.1%)
$5.98 B(+13.2%)
June 2008
-
$779.50 M(-45.5%)
$5.29 B(+9.0%)
Mar 2008
-
$1.43 B(-23.2%)
$4.85 B(+19.1%)
Dec 2007
$4.07 B
$1.86 B(+53.4%)
$4.07 B(+11.4%)
Sept 2007
-
$1.21 B(+254.8%)
$3.66 B(+9.4%)
June 2007
-
$342.30 M(-47.5%)
$3.34 B(-3.3%)
DateAnnualQuarterlyTTM
Mar 2007
-
$652.40 M(-54.9%)
$3.46 B(+19.3%)
Dec 2006
$2.90 B(+370.9%)
$1.45 B(+60.8%)
$2.90 B(+57.1%)
Sept 2006
-
$900.30 M(+97.3%)
$1.85 B(+501.8%)
June 2006
-
$456.30 M(+386.5%)
$306.60 M(+109.0%)
Mar 2006
-
$93.80 M(-76.2%)
$146.70 M(-76.2%)
Dec 2005
$615.50 M(-36.6%)
$394.70 M(-161.8%)
$615.50 M(+105.7%)
Sept 2005
-
-$638.20 M(-315.3%)
$299.20 M(-76.6%)
June 2005
-
$296.40 M(-47.3%)
$1.28 B(-9.8%)
Mar 2005
-
$562.60 M(+617.6%)
$1.42 B(+46.2%)
Dec 2004
$971.40 M(-49.9%)
$78.40 M(-77.2%)
$971.40 M(-30.7%)
Sept 2004
-
$343.50 M(-21.2%)
$1.40 B(-19.4%)
June 2004
-
$436.10 M(+284.6%)
$1.74 B(-0.2%)
Mar 2004
-
$113.40 M(-77.7%)
$1.74 B(-10.2%)
Dec 2003
$1.94 B(+106.4%)
$508.80 M(-25.3%)
$1.94 B(+11.8%)
Sept 2003
-
$680.70 M(+54.6%)
$1.74 B(+33.1%)
June 2003
-
$440.20 M(+41.8%)
$1.30 B(+8.2%)
Mar 2003
-
$310.40 M(+2.1%)
$1.20 B(+28.2%)
Dec 2002
$939.80 M(-66.2%)
$304.10 M(+22.1%)
$939.80 M(-33.0%)
Sept 2002
-
$249.00 M(-27.0%)
$1.40 B(-28.4%)
June 2002
-
$341.20 M(+649.9%)
$1.96 B(-20.0%)
Mar 2002
-
$45.50 M(-94.1%)
$2.45 B(-11.8%)
Dec 2001
$2.78 B(-9.0%)
$767.20 M(-4.7%)
$2.78 B(-2.4%)
Sept 2001
-
$805.40 M(-3.1%)
$2.85 B(-8.9%)
June 2001
-
$831.40 M(+122.5%)
$3.12 B(+6.7%)
Mar 2001
-
$373.60 M(-55.3%)
$2.93 B(-4.1%)
Dec 2000
$3.05 B(+46.0%)
$835.00 M(-22.9%)
$3.05 B(+3.1%)
Sept 2000
-
$1.08 B(+70.6%)
$2.96 B(+1.3%)
June 2000
-
$635.10 M(+27.0%)
$2.92 B(+5.0%)
Mar 2000
-
$500.20 M(-32.7%)
$2.79 B(+33.2%)
Dec 1999
$2.09 B(-5.4%)
$743.10 M(-29.0%)
$2.09 B(-7.0%)
Sept 1999
-
$1.05 B(+111.1%)
$2.25 B(+16.3%)
June 1999
-
$495.70 M(-355.6%)
$1.93 B(-5.1%)
Mar 1999
-
-$193.90 M(-121.6%)
$2.04 B(-7.9%)
Dec 1998
$2.21 B(+8.6%)
$899.70 M(+23.0%)
$2.21 B(+4.4%)
Sept 1998
-
$731.60 M(+22.1%)
$2.12 B(+17.5%)
June 1998
-
$599.00 M(-3036.3%)
$1.80 B(+1.9%)
Mar 1998
-
-$20.40 M(-102.5%)
$1.77 B(-13.0%)
Dec 1997
$2.03 B(+31.4%)
$806.40 M(+93.6%)
$2.03 B(+10.1%)
Sept 1997
-
$416.60 M(-26.4%)
$1.85 B(+3.6%)
June 1997
-
$566.10 M(+131.1%)
$1.78 B(+6.6%)
Mar 1997
-
$245.00 M(-60.5%)
$1.67 B(+8.1%)
Dec 1996
$1.55 B(+21.5%)
$620.40 M(+76.1%)
$1.55 B(+0.8%)
Sept 1996
-
$352.30 M(-22.6%)
$1.54 B(+14.0%)
June 1996
-
$454.90 M(+279.4%)
$1.35 B(+11.7%)
Mar 1996
-
$119.90 M(-80.3%)
$1.21 B(-5.3%)
Dec 1995
$1.27 B(+33.2%)
$608.40 M(+271.4%)
$1.27 B(+30.0%)
Sept 1995
-
$163.80 M(-47.9%)
$979.50 M(-19.8%)
June 1995
-
$314.20 M(+68.1%)
$1.22 B(+12.4%)
Mar 1995
-
$186.90 M(-40.6%)
$1.09 B(+13.7%)
Dec 1994
$955.80 M(+8.2%)
$314.60 M(-22.3%)
$955.80 M(-0.1%)
Sept 1994
-
$405.00 M(+125.0%)
$957.10 M(+5.6%)
June 1994
-
$180.00 M(+220.3%)
$906.30 M(+0.4%)
Mar 1994
-
$56.20 M(-82.2%)
$902.30 M(+2.1%)
Dec 1993
$883.40 M(+83.5%)
$315.90 M(-10.8%)
$883.40 M(+0.6%)
Sept 1993
-
$354.20 M(+101.3%)
$878.10 M(+36.4%)
June 1993
-
$176.00 M(+371.8%)
$644.00 M(+44.3%)
Mar 1993
-
$37.30 M(-88.0%)
$446.40 M(-7.3%)
Dec 1992
$481.40 M(+329.1%)
$310.60 M(+158.6%)
$481.40 M(+75.6%)
Sept 1992
-
$120.10 M(-656.0%)
$274.20 M(-19.4%)
June 1992
-
-$21.60 M(-129.9%)
$340.30 M(+41.4%)
Mar 1992
-
$72.30 M(-30.1%)
$240.60 M(+114.4%)
Dec 1991
$112.20 M(-76.0%)
$103.40 M(-44.5%)
$112.20 M(+190.7%)
Sept 1991
-
$186.20 M(-253.5%)
$38.60 M(-64.6%)
June 1991
-
-$121.30 M(+116.2%)
$109.10 M(-60.0%)
Mar 1991
-
-$56.10 M(-288.3%)
$272.60 M(-41.6%)
Dec 1990
$467.10 M(-2.3%)
$29.80 M(-88.4%)
$467.10 M(+6.8%)
Sept 1990
-
$256.70 M(+508.3%)
$437.30 M(+142.1%)
June 1990
-
$42.20 M(-69.5%)
$180.60 M(+30.5%)
Mar 1990
-
$138.40 M
$138.40 M
Dec 1989
$478.10 M
-
-

FAQ

  • What is Eli Lilly and Company annual free cash flow?
  • What is the all time high annual FCF for Eli Lilly and Company?
  • What is Eli Lilly and Company annual FCF year-on-year change?
  • What is Eli Lilly and Company quarterly free cash flow?
  • What is the all time high quarterly FCF for Eli Lilly and Company?
  • What is Eli Lilly and Company quarterly FCF year-on-year change?
  • What is Eli Lilly and Company TTM free cash flow?
  • What is the all time high TTM FCF for Eli Lilly and Company?
  • What is Eli Lilly and Company TTM FCF year-on-year change?

What is Eli Lilly and Company annual free cash flow?

The current annual FCF of LLY is -$3.15 B

What is the all time high annual FCF for Eli Lilly and Company?

Eli Lilly and Company all-time high annual free cash flow is $6.23 B

What is Eli Lilly and Company annual FCF year-on-year change?

Over the past year, LLY annual free cash flow has changed by -$7.75 B (-168.52%)

What is Eli Lilly and Company quarterly free cash flow?

The current quarterly FCF of LLY is -$458.90 M

What is the all time high quarterly FCF for Eli Lilly and Company?

Eli Lilly and Company all-time high quarterly free cash flow is $2.10 B

What is Eli Lilly and Company quarterly FCF year-on-year change?

Over the past year, LLY quarterly free cash flow has changed by +$1.35 B (+74.67%)

What is Eli Lilly and Company TTM free cash flow?

The current TTM FCF of LLY is -$2.28 B

What is the all time high TTM FCF for Eli Lilly and Company?

Eli Lilly and Company all-time high TTM free cash flow is $6.23 B

What is Eli Lilly and Company TTM FCF year-on-year change?

Over the past year, LLY TTM free cash flow has changed by -$2.11 B (-1279.81%)